title: CD2AP/CMS regulates endosome morphology and traffic to the degradative pathway through its interaction with Rab4 and c-Cbl.
abstract: The small GTPase Rab4 is involved in endocytosis through sorting and recycling early endosomes. To better understand the role of Rab4 in regulation of vesicular trafficking, we searched for effectors that specifically interact with Rab4-Q67L, the GTP-bound form of Rab4. We cloned an ubiquitous 80-kDa protein, identical to CD2-associated protein/Cas ligand with multiple SH3 domains (CD2AP/CMS), that interacts with Rab4-Q67L in the yeast two-hybrid system and in vitro. CD2AP/CMS expressed in mammalian cells was localized to punctate structures and along actin filaments. None of the known markers of early endosomes [Early Endosomes Antigen 1 (EEA1), Rab5 and Rab11] colocalized with the CD2AP/CMS-positive vesicles. However, coexpression of Rab4-Q67L with CD2AP/CMS induces a significant enlargement of EEA1-positive early endosomes. Rab4, CD2AP/CMS and Rab7 colocalized in these modified endosomes. Coexpression of c-Cbl and CD2AP/CMS also resulted in an enlargement of early endosomes. Using various truncated forms of CD2AP/CMS, we demonstrate that early endosomes enlargement requires that CD2AP/CMS interacts with both Rab4 and c-Cbl. The expression of a truncated form of CD2AP/CMS that retains the ability to interact with Rab4 but not c-Cbl inhibits ligand-induced PDGF receptor degradation. We propose that CD2AP/CMS, through interactions with Rab4 and c-Cbl, controls early endosome morphology and may play a role in traffic between early and late endosomes, and thus in the degradative pathway.
authors.affiliation: Inserm U568, IFR 50, Faculty of Medicine, University of Nice, 06107 Nice cedex 02, France. cormont@unice.fr
authors.forename: Mireille
authors.initials: M
authors.lastname: Cormont
authors.forename: Isidoro
authors.initials: I
authors.lastname: Metón
authors.forename: Muriel
authors.initials: M
authors.lastname: Mari
authors.forename: Pascale
authors.initials: P
authors.lastname: Monzo
authors.forename: Frédérique
authors.initials: F
authors.lastname: Keslair
authors.forename: Chantell
authors.initials: C
authors.lastname: Gaskin
authors.forename: Timothy E
authors.initials: TE
authors.lastname: McGraw
authors.forename: Yannick
authors.initials: Y
authors.lastname: Le Marchand-Brustel
mesh_terms: D008841:Actin Cytoskeleton / Q000378:metabolism; D048868:Adaptor Proteins, Signal Transducing; D000818:Animals; D016466:CHO Cells; D006224:Cricetinae; D003598:Cytoskeletal Proteins; D011992:Endosomes / Q000378:metabolism*; D006801:Humans; D008856:Microscopy, Fluorescence; D011506:Proteins / Q000378:metabolism*; D011518:Proto-Oncogene Proteins / Q000378:metabolism*; D050721:Proto-Oncogene Proteins c-cbl; D017479:Receptors, Platelet-Derived Growth Factor / Q000378:metabolism; D011990:Receptors, Transferrin / Q000378:metabolism; D044767:Ubiquitin-Protein Ligases; D020695:rab4 GTP-Binding Proteins / Q000378:metabolism*
chemical_list: D048868:Adaptor Proteins, Signal Transducing; C114545:CD2-associated protein; D003598:Cytoskeletal Proteins; D011506:Proteins; D011518:Proto-Oncogene Proteins; D011990:Receptors, Transferrin; D050721:Proto-Oncogene Proteins c-cbl; D044767:Ubiquitin-Protein Ligases; D017479:Receptors, Platelet-Derived Growth Factor; D020695:rab4 GTP-Binding Proteins; C067419:CBL protein, human